Multiparametric quantitative analysis of tumor perfusion and diffusion with 3T MRI: differentiation between benign and malignant soft tissue tumors
Seul Ki Lee, Won-Hee Jee, Chan Kwon Jung, Yang‐Guk Chung
Abstract
Objective: To evaluate multiparametric MRI for differentiating benign and malignant soft tissue tumors. Methods: This retrospective study included 67 patients (mean age, 55 years; 18–82 years) with 35 benign and 32 malignant soft tissue tumors. Intravoxel incoherent motion diffusion-weighted imaging (IVIM-DWI)-derived parameters (D, D*, f), apparent diffusion coefficient (ADC), and dynamic contrast-enhanced (DCE)-MRI parameters (K trans , K ep , V e , iAUC) were calculated. Myxoid and non-myxoid soft tissue tumors were divided for subgroup analysis. The parameters were compared between benign and malignant tumors. Results: ADC and D were significantly lower in malignant than benign soft tissue tumors (1170 ± 488 vs 1472 ± 349 µm 2 /s; 1132 ± 500 vs 1415 ± 374 µm 2 /s; p < 0.05). K trans , K ep , V e , and iAUC were significantly different between malignant and benign soft tissue tumors (0.209 ± 0.160 vs 0.092 ± 0.067 min −1 ; 0.737 ± 0.488 vs 0.311 ± 0.230 min −1 ; 0.32 ± 0.17 vs 0.44 ± 0.28; 0.23 ± 0.14 vs 0.12 ± 0.09, p < 0.05, respectively). ADC (0.752), D (0.742), and K ep (0.817) had high AUCs. Subgroup analysis showed that only K trans , and iAUC were significantly different in myxoid tumors, while, ADC, D, K trans , K ep , and iAUC were significantly different in non-myxoid tumor for differentiating benign and malignant tumors. D, K ep , and iAUC were the most significant parameters predicting malignant soft tissue tumors. Conclusion: Multiparametric MRI can be useful to differentiate benign and malignant soft tissue tumors using IVIM-DWI and DCE-MRI. Advances in knowledge: 1. Pure tissue diffusion (D), transfer constant (K trans ), rate constant (K ep ), and initial area under time–signal intensity curve (iAUC) can be used to differentiate benign malignant soft tissue tumors. 2. K trans and iAUC enable differentiation of benign and malignant myxoid soft tissue tumors.